Haemonetics Corp (HAE)
94.48
-0.32
(-0.34%)
USD |
NYSE |
May 17, 09:55
Haemonetics Price to Book Value: 4.998 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 5.015 |
| May 15, 2024 | 5.105 |
| May 14, 2024 | 5.151 |
| May 13, 2024 | 5.090 |
| May 10, 2024 | 5.071 |
| May 09, 2024 | 4.899 |
| May 08, 2024 | 4.933 |
| May 07, 2024 | 5.036 |
| May 06, 2024 | 5.046 |
| May 03, 2024 | 4.994 |
| May 02, 2024 | 4.938 |
| May 01, 2024 | 4.874 |
| April 30, 2024 | 4.865 |
| April 29, 2024 | 4.841 |
| April 26, 2024 | 4.814 |
| April 25, 2024 | 4.638 |
| April 24, 2024 | 4.561 |
| April 23, 2024 | 4.501 |
| April 22, 2024 | 4.424 |
| April 19, 2024 | 4.298 |
| April 18, 2024 | 4.415 |
| April 17, 2024 | 4.490 |
| April 16, 2024 | 4.453 |
| April 15, 2024 | 4.490 |
| April 12, 2024 | 4.508 |
| Date | Value |
|---|---|
| April 11, 2024 | 4.577 |
| April 10, 2024 | 4.558 |
| April 09, 2024 | 4.606 |
| April 08, 2024 | 4.514 |
| April 05, 2024 | 4.478 |
| April 04, 2024 | 4.491 |
| April 03, 2024 | 4.440 |
| April 02, 2024 | 4.453 |
| April 01, 2024 | 4.486 |
| March 31, 2024 | |
| March 28, 2024 | 4.595 |
| March 27, 2024 | 4.527 |
| March 26, 2024 | 4.395 |
| March 25, 2024 | 4.405 |
| March 22, 2024 | 4.322 |
| March 21, 2024 | 4.323 |
| March 20, 2024 | 4.297 |
| March 19, 2024 | 4.173 |
| March 18, 2024 | 4.080 |
| March 15, 2024 | 4.028 |
| March 14, 2024 | 4.070 |
| March 13, 2024 | 4.11 |
| March 12, 2024 | 4.138 |
| March 11, 2024 | 4.219 |
| March 08, 2024 | 4.286 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.061
Minimum
Jan 27 2022
11.90
Maximum
Aug 16 2019
6.372
Average
5.258
Median
Price to Book Value Benchmarks
| Stryker Corp | 6.628 |
| ResMed Inc | 6.978 |
| Masimo Corp | 4.676 |
| Insulet Corp | 16.40 |
| InfuSystems Holdings Inc | 2.587 |
Price to Book Value Related Metrics
| PE Ratio | 41.26 |
| PS Ratio | 3.710 |
| PEG Ratio | 15.33 |
| Price to Free Cash Flow | 42.06 |
| Price | 94.48 |
| Earnings Yield | 2.42% |
| Market Cap | 4.798B |
| PEGY Ratio | 15.33 |
| Operating PE Ratio | 27.70 |
| Normalized PE Ratio | 38.66 |